Abiraterone Tablet
Product Images NDC 72205-030

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone (NDC 72205-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250-mg-120s (Abiraterone 250mg 120s Container Label)

This is a prescription medication called Abiraterone Acetate & wrony tablets USP used for treating certain types of cancer. Each tablet contains 250 mg of Abiraterone acetate. The dosage instructions state to swallow the tablet whole and not crush or chew it. It is harmful if taken by pregnant women and they should avoid handling the tablets without gloves. The medication comes in a package of 120 tablets manufactured by SN Laboratories Private Limited and distributed by Novados Pharmaceuticals. The NDC number of the product is 72205-03.*

FDA Label Image

Figure-01 (Abiraterone Figure 01)

This appears to be the visual representation of data from a clinical trial for the drugs Abiraterone and Placebo in the treatment of a medical condition resulting in death. The chart shows the time to death, in months, for patients who received Abiraterone versus those who received a placebo. The y-axis shows the percentage of patients still alive at that time-point, while the x-axis shows the time in months. The chart indicates that the survival rate for patients receiving Abiraterone is significantly higher than for those who received a placebo.*

FDA Label Image

Figure-02 (Abiraterone Figure 02)

This text presents a visualization of the percentage of subjects without death, over a 60-month period, for the drugs Abiraterone and Placebo. The chart shows that Abiraterone had a higher percentage of subjects without death than the Placebo medication.*

FDA Label Image

Figure-03 (Abiraterone Figure 03)

FDA Label Image

Abiraterone-structure (Abiraterone Structure)

FDA Label Image

Figure 4

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.